Controlant, whose platform tracks critical condition parameters for pharmaceutical and healthcare products, announced today that its solution would be deployed in all of World Courier’s multi-use packages, providing World Courier with increased real-time visibility into the precise location of shipments globally.
AmerisourceBergen’s World Courier is a global specialty logistics provider and this technology will enhance their ability to proactively monitor shipments, anticipate potential risks, and intervene, if needed, to ensure the secure and timely distribution of products. This further supports their customers’ need for transparency, risk management, efficiency, and resilience.
“This partnership is an important milestone in the industry,” says Hristo Petkov, Vice President of Partnerships at Controlant. “Real-time visibility is a game changer for global supply chains. Controlant and World Courier share a commitment to driving innovation in this field to address the growing need for visibility and transparency, utilizing data to drive improved services, and to ensure peace of mind and satisfaction for customers.”
“Advances in digital technology continue to unlock new ways to manage and monitor the shipment of pharmaceutical products,” says Simon Brinckmann, Senior Director of Business Excellence & Innovation at World Courier.
“Technology that provides reliable, real-time monitoring data is an increasingly important part of an effective logistics operation, particularly because the products we are handling today are more complex and sensitive. By adding Controlant’s technology to our packaging, we are creating a new standard for tracking in the pharmaceutical logistics industry and providing our customers with enhanced logistics support.”
This technology enables logistics providers to be more efficient and sustainable, improve asset utilization, optimize quality, and future-proof their operations; altogether creating greener supply chains and driving a sustainable mindset in logistics.
Petkov: “The collaboration is an important use case for Controlant’s value proposition of real-time visibility through digitalization, using software to generate insights, and platform solutions to achieve better business outcomes. It builds on capabilities that we have demonstrated in the past with companies including Pfizer, Roche, and Teva, and further opens opportunities for better transparency, better planning, and greater quality compliance in pharma logistics.”
The promise of modern medicine to improve lives and cure more diseases than ever before can only be fulfilled when pharma supply chains provide on-time, safe, and sustainable delivery to patients wherever they may be. Digitalization is the key to unlocking the potential of supply chains to be a strategic enabler in today’s complex and ever-changing market and to achieve zero waste. Controlant’s validated, cloud-based Aurora Platform can be coupled with devices and services for a holistic solution framework designed to digitalize and automate pharma supply chains.
The Science Based Targets initiative (SBTi) has validated Controlant’s near-term climate target to reduce scope 1 and 2 greenhouse gas (GHG) emissions by 42% by 2030. With a validated target, Controlant becomes one of the first companies among its global industry peers to have a validated science-based target. Joining the initiative is a vital step for Controlant in its mission to deliver zero-waste pharma supply chains and ensure its climate actions are in line with the latest climate science.
UNICEF and Controlant have signed a partnership agreement with a focus on life-saving child immunization. Over the next three years, Controlant will donate to UNICEF yearly for its tireless work that has a direct, positive impact on children across the world.